Acutaas Chemicals Quarterly Results for Trading Insights
ACUTAAS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹72 Cr
QSept 2025
Acutaas Chemicals Quarterly Results Key Highlights
- Revenue of ₹316 Cr in Sept 2025 (+0.6% vs Mar 2025, +23.9% vs Sept 2024)
- Net Profit of ₹72 Cr in Sept 2025 (+14.3% vs Mar 2025, +89.5% vs Sept 2024)
- EBITDA of ₹105 Cr in Sept 2025 (+15.4% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+3.0pp vs Mar 2025)
- Earnings Per Share of ₹8.82 in Sept 2025 (+13.1% vs Mar 2025)
Acutaas Chemicals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 316 | 314 | 223 | 398 | 255 | 0.6% | 23.9% |
| Net Profit (₹ Cr) | 72 | 63 | 44 | 106 | 38 | - | - |
| EBITDA (₹ Cr) | 105 | 91 | 67 | 155 | 57 | - | - |
| EPS (₹) | 8.82 | 7.80 | 5.41 | 13.19 | 9.38 | - | - |
| Operating Margin (%) | 31.0% | 28.0% | 25.0% | 38.0% | 20.0% | - | - |
Acutaas Chemicals Share Price Trend Around Quarterly Results
Visualize Acutaas Chemicals's 1-year price movement across quarterly results — ideal for logging trades in Acutaas Chemicals share price
chart using Tickjournal. All values in ₹.
Related Pages for Acutaas Chemicals
Additional stock information and data for ACUTAAS
Revenue Trend (₹ Cr)
Dec 2025
398
Jun 2025
223
Mar 2025
314
Sept 2025
316
Net Profit Trend (₹ Cr)
Dec 2025
106
Jun 2025
44
Mar 2025
63
Sept 2025
72
Operating Margin Trend (%)
Dec 2025
38.0%
Jun 2025
25.0%
Mar 2025
28.0%
Sept 2025
31.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Acutaas Chemicals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores